Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton.

Source:http://linkedlifedata.com/resource/pubmed/id/16985069

Download in:

View as

General Info

PMID
16985069